South African biotech Afrigen Biologics has secured a $6.2m grant from the Coalition for Epidemic Preparedness Innovations (CEPI) to develop the first mRNA-based vaccine against Rift Valley fever.

Global efforts for a Rift Valley fever (RVF) vaccine accelerate as South Africa’s Afrigen Biologics begins local development of mRNA vaccine. With no vaccine approved for human use yet ...

have urged East African countries to create awareness and increase preparedness due to a potential outbreak of the Rift Valley Fever. The RVF warnings are predicted to be on the rise following the ...

I currently have 41 sheep, 53 goats and 20 cows which I keep as free range. The news of Rift Valley Fever outbreak in parts of the country are worrying me. In 2006, I lost a number of animals to ...

Separately, the Central African Republic's Health Ministry declared 12 suspected cases of Rift Valley fever on Thursday. These cases were reported in the northwestern sub-prefecture of Ngaoundaye ...